With 20 years of transfection experience, Roche offers two next-generation transfection reagents, X-tremeGENE HP and X-tremeGENE 9 Reagents, that deliver reliability and comprehensive efficiency across common and hard-to-transfect cell lines. Created to meet the needs of researchers who require high efficiency, ease-of-use, and reproducibility, X-tremeGENE Transfection Reagents provide more viable cells and more physiologically relevant results. Built by the experts in transfection, X-tremeGENE transfection reagents offer a simple and straightforward protocol, best-in-class cytotoxicity levels, and excellent performance, allowing researchers to transfect with confidence.

X-tremeGENE is a trademark of Roche. For life science research only. Not for use in diagnostic procedures.